Cargando…

Effects of Mesenchymal Stem Cell Treatment on Systemic Cytokine Levels in a Phase 1 Dose Escalation Safety Trial of Septic Shock Patients*

OBJECTIVES: Cellular Immunotherapy for Septic Shock is the first-in-human clinical trial evaluating allogeneic mesenchymal stem/stromal cells in septic shock patients. Here, we sought to determine whether plasma cytokine profiles may provide further information into the safety and biological effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schlosser, Kenny, Wang, Jia-Pey, dos Santos, Claudia, Walley, Keith R., Marshall, John, Fergusson, Dean A., Winston, Brent W., Granton, John, Watpool, Irene, Stewart, Duncan J., McIntyre, Lauralyn A., Mei, Shirley H. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629173/ https://www.ncbi.nlm.nih.gov/pubmed/30720538 http://dx.doi.org/10.1097/CCM.0000000000003657

Ejemplares similares

Metabolomics Analysis of Mesenchymal Stem Cell (MSC) Therapy in a Phase I Clinical Trial of Septic Shock: An Exploratory Study
por: Banoei, Mohammad M., et al.
Publicado: (2023)

Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
por: Lalu, Manoj M., et al.
Publicado: (2012)

A survey of Canadian intensivists' resuscitation practices in early septic shock
por: McIntyre, Lauralyn A, et al.
Publicado: (2007)

Lack of elevation in plasma levels of pro-inflammatory cytokines in common rodent models of pulmonary arterial hypertension: questions of construct validity for human patients
por: Schlosser, Kenny, et al.
Publicado: (2017)

Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis
por: Thompson, Mary, et al.
Publicado: (2020)

Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
por: Lalu, Manoj M, et al.
Publicado: (2016)

Thawed Mesenchymal Stem Cell Product Shows Comparable Immunomodulatory Potency to Cultured Cells In Vitro and in Polymicrobial Septic Animals
por: Tan, Yuan, et al.
Publicado: (2019)

Customized Internal Reference Controls for Improved Assessment of Circulating MicroRNAs in Disease
por: Schlosser, Kenny, et al.
Publicado: (2015)

High circulating angiopoietin-2 levels exacerbate pulmonary inflammation but not vascular leak or mortality in endotoxin-induced lung injury in mice
por: Schlosser, Kenny, et al.
Publicado: (2018)

Multicountry survey of emergency and critical care medicine physicians’ fluid resuscitation practices for adult patients with early septic shock
por: McIntyre, Lauralyn, et al.
Publicado: (2016)

Assessment of Circulating LncRNAs Under Physiologic and Pathologic Conditions in Humans Reveals Potential Limitations as Biomarkers
por: Schlosser, Kenny, et al.
Publicado: (2016)

Poly(I:C) enhances mesenchymal stem cell control of myeloid cells from COVID-19 patients
por: Souza-Moreira, Luciana, et al.
Publicado: (2022)

Cytokine levels is septic shock
por: Mateu Campos, L, et al.
Publicado: (2015)

Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine
por: Mehta, Sangeeta, et al.
Publicado: (2013)

Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol
por: Suen, Colin M., et al.
Publicado: (2016)

Erratum to: Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine
por: Mehta, Sangeeta, et al.
Publicado: (2017)

Cytokine adsorption in severe, refractory septic shock
por: Wendel Garcia, Pedro David, et al.
Publicado: (2021)

The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research
por: Avey, Marc T., et al.
Publicado: (2016)

Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol
por: Lalu, Manoj M, et al.
Publicado: (2014)

Red blood cell transfusion and mortality effect in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis protocol
por: English, Shane W, et al.
Publicado: (2015)

Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review
por: Suen, Colin M., et al.
Publicado: (2019)

Cytokine and Chemokine Profiling in Cats With Sepsis and Septic Shock
por: Troia, Roberta, et al.
Publicado: (2020)

Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review
por: McIntyre, Lauralyn A., et al.
Publicado: (2016)

Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol
por: Barron, Carly C., et al.
Publicado: (2017)

Albumin in early septic shock resuscitation: examination of plasma and urine inflammatory markers
por: Fox-Robichaud, A, et al.
Publicado: (2012)

The conundrum of persistent inappropriate use of frozen plasma
por: Tinmouth, Alan T, et al.
Publicado: (2011)

Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials: ATTENTION: The analysis and conclusions of this article are being revised by the authors. This is due to the journal Anesthesia and Analgesia's retraction of a paper by Dr. Joachim Boldt, an author in seven of the studies analyzed in this review. As such, the editors of Open Medicine recommend interpreting this review with extreme caution until Zarychanski et al. publish a new analysis and interpretation in Open Medicine. For more information, see Anesthesia and Analgesia's press release.
por: Zarychanski, Ryan, et al.
Publicado: (2009)

Comparison of crystalloid resuscitation fluids for treatment of acute brain injury: a clinical and pre-clinical systematic review and network meta-analysis protocol
por: Thompson, Mary, et al.
Publicado: (2018)

Early May Be Better: Early Low-Dose Norepinephrine in Septic Shock
por: Russell, James A., et al.
Publicado: (2019)

Subarachnoid hemorrhage admissions retrospectively identified using a prediction model
por: English, Shane W., et al.
Publicado: (2016)

Immunoregulatory biological response modifiers: effect of cytokines on septic shock
por: Chirigos, Michael A., et al.
Publicado: (1993)

The time course of adrenocortical hormones and cytokines in sepsis and/or septic shock
por: Dimopoulou, I, et al.
Publicado: (2005)

Vitamin D deficiency in critically ill children: a systematic review and meta-analysis
por: McNally, James Dayre, et al.
Publicado: (2017)

Significance of lactate clearance in septic shock patients with high bilirubin levels
por: Takahashi, Nozomi, et al.
Publicado: (2021)

Escalation and de-escalation of mechanical circulatory support in cardiogenic shock
por: Bertoldi, Letizia F, et al.
Publicado: (2021)

Transfusion of red blood cells in patients with traumatic brain injuries admitted to Canadian trauma health centres: a multicentre cohort study
por: Boutin, Amélie, et al.
Publicado: (2017)

The role of endotoxin in septic shock
por: Kellum, John A., et al.
Publicado: (2023)

Plasmatic cytokines and intermittent hemodialysis with polymethylmethacrylate membrane in septic shock patients
por: Mayeur, N, et al.
Publicado: (2009)

Ultrasensitive digital quantification of cytokines and bacteria predicts septic shock outcomes
por: Abasıyanık, M. Fatih, et al.
Publicado: (2020)

Hyperchloremia and moderate increase in serum chloride are associated with acute kidney injury in severe sepsis and septic shock patients
por: Suetrong, Bandarn, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kbbfpg58hl85qumh9f4qn76mub